(redirected from growth hormone receptor antagonist)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
References in periodicals archive ?
That market is currently dominated by once-a-month Sandostatin LAR(R) Depot (octreotide acetate for injectable suspension) from Novartis (NYSE: NVS) and includes daily injections of Somavert (pegvisomant for injection), a growth hormone receptor antagonist, from Pfizer (NYSE: PFE).
Shearwater") today announced a license agreement with Sensus Drug Development Corporation ("Sensus") for the PEGylation of Sensus' Somavert(TM) (pegvisomant for injection) human growth hormone receptor antagonist using Shearwater's proprietary technology.
Sensus Drug Development Corporation today announced the positive results of its pivotal Phase III clinical trial with its lead compound, pegvisomant (B2036-PEG), a novel growth hormone receptor antagonist.

Full browser ?